⌘K

Login Start Free

Home/Filings/4/0000950142-22-001934

4//SEC Filing

Shumway Chris 4

Accession 0000950142-22-001934

CIK 0001733257other

View on SEC.gov Company Profile

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 5:15 PM ET

Size

5.4 KB

Accession

0000950142-22-001934

Insider Transaction Report

Form 4

Period: 2022-06-13

Finch Therapeutics Group, Inc.FNCH

Director10% Owner

Transactions

Award
Stock Option (right to buy)
2022-06-13+44,843→ 44,843 total
Exercise: $2.79Exp: 2032-06-12→ Common Stock (44,843 underlying)

Footnotes (1)

[F1]The shares subject to this option shall vest in twelve equal monthly installments beginning on July 13, 2022, subject to the Reporting Person continuing to provide service through each such date.

Documents

1 file

4
es220262423_4-finch.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Finch Therapeutics Group, Inc.

CIK 0001733257

Entity typeother

Related Parties

1

filerCIK 0001222119

Filing Metadata

Form type: 4
Filed: Jun 14, 8:00 PM ET
Accepted: Jun 15, 5:15 PM ET
Size: 5.4 KB

View on SEC.gov